0
Skip to Content
Solaris SRB
About
Services
Contact
Blogs
Testimonials
Resources
CONTACT US
Solaris SRB
About
Services
Contact
Blogs
Testimonials
Resources
CONTACT US
About
Services
Contact
Blogs
Testimonials
Resources
CONTACT US
Scientific Considerations in Demonstrating Biosimilarity to a Reference Product: Updated Recommendations for Assessing the Need for Comparative Efficacy Studies
Katie Laney 11/18/25 Katie Laney 11/18/25

Scientific Considerations in Demonstrating Biosimilarity to a Reference Product: Updated Recommendations for Assessing the Need for Comparative Efficacy Studies

Learn more about the latest FDA Guidance, “Scientific Considerations in Demonstrating Biosimilarity to a Reference Product: Updated Recommendations for Assessing the Need for Comparative Efficacy Studies” now open to the public for comment.

Read More
 I SOOOO WANT TO KNOW ISO/IEC 27001 for Information Security, Cybersecurity and Privacy Protection
Katie Laney 11/10/25 Katie Laney 11/10/25

I SOOOO WANT TO KNOW ISO/IEC 27001 for Information Security, Cybersecurity and Privacy Protection

Check out our latest blog on ISO 27001!

Read More
The Relationship with Our “X’s”: Good Clinical Practice – One of the “X’s” in GXP
Katie Laney 11/4/25 Katie Laney 11/4/25

The Relationship with Our “X’s”: Good Clinical Practice – One of the “X’s” in GXP

Our latest blog covers Good Clinical Practices and the recent guidance: E6(R3) Good Clinical Practice, Guidance for Industry. Learn the global role of the International Council for Harmonisation (ICH) and where they fit into this topic!

Read More
Moving from Manual Systems – Automation in Progress for Tissue Bank Establishments
Katie Laney 10/27/25 Katie Laney 10/27/25

Moving from Manual Systems – Automation in Progress for Tissue Bank Establishments

Is your organization seeking to modernize and implement ERP Systems? This blog covers the transition from manual systems with regard to Tissue Bank Establishments

Read More
Computer Software Assurance for Production and Quality System Software
Katie Laney 10/21/25 Katie Laney 10/21/25

Computer Software Assurance for Production and Quality System Software

Today’s blog covers key points on the approach an establishment should take with regard to validation and assurance of software used in medical device production and quality systems.

Read More
The Critical Role of Donor Eligibility Determination – Safeguarding Recipients
Katie Laney 10/13/25 Katie Laney 10/13/25

The Critical Role of Donor Eligibility Determination – Safeguarding Recipients

Today’s blog post covers Donor Eligibility Requirements, guided by FDA and AATB regulations, to safeguard recipients and transform lives

Read More
Navigating Medical Device Manufacturing – 510(k), PMA, De Novo, Oh My!
Katie Laney 10/6/25 Katie Laney 10/6/25

Navigating Medical Device Manufacturing – 510(k), PMA, De Novo, Oh My!

Learn all about Medical Device Manufacturing in today’s blog!

Read More
Introduction to the Basics of the Biologics License Application (BLA) Process
Katie Laney 9/29/25 Katie Laney 9/29/25

Introduction to the Basics of the Biologics License Application (BLA) Process

Today’s blog covers the phases and process of Biologics License Application (BLA).

Read More
Complete Response Letters – When Your Submission Application Isn’t Granted
Katie Laney 9/22/25 Katie Laney 9/22/25

Complete Response Letters – When Your Submission Application Isn’t Granted

The latest blog covers Complete Response Letters and the recent publication that FDA has released.

Read More
Investigational New Drug (IND) Applications for HCT/Ps: How do I get there?
Katie Laney 9/15/25 Katie Laney 9/15/25

Investigational New Drug (IND) Applications for HCT/Ps: How do I get there?

Read More
Training: The Critical Role in Tissue Banking
Katie Laney 9/3/25 Katie Laney 9/3/25

Training: The Critical Role in Tissue Banking

Our newest blog covers the importance of training in tissue banking, and how to refine your process!

Read More
Quality Agreements – The Robust Cornerstone of Tissue Safety and Compliance
Katie Laney 8/26/25 Katie Laney 8/26/25

Quality Agreements – The Robust Cornerstone of Tissue Safety and Compliance

Our newest blog covers Quality Agreements! What are they?, what are the benefits, and how to build an effective Quality Agreement

Read More
Machine Learning: The Era of Artificial Intelligence in Our Industry – 101
Katie Laney 8/18/25 Katie Laney 8/18/25

Machine Learning: The Era of Artificial Intelligence in Our Industry – 101

Today’s blog provides the basics of understanding Artificial Intelligence in the Life Sciences Industry

Read More
Quality Management System Audits: Navigating 21 CFR 1271 and AATB
Katie Laney 8/11/25 Katie Laney 8/11/25

Quality Management System Audits: Navigating 21 CFR 1271 and AATB

This blog features navigating Internal Quality Audits!

Read More
Pipeline News for Hepatitis B Surface Antigen Testing in Blood Banking and Will This Impact HCT/Ps?
Katie Laney 8/4/25 Katie Laney 8/4/25

Pipeline News for Hepatitis B Surface Antigen Testing in Blood Banking and Will This Impact HCT/Ps?

Our newest blog is a review of the recent FDA Draft Guidance release on potential changes to Hepatitis B Testing for Blood Products

Read More
Update: Comment Period Ends – AATB Response to FDA Draft Guidance Document Sepsis
Katie Laney 7/28/25 Katie Laney 7/28/25

Update: Comment Period Ends – AATB Response to FDA Draft Guidance Document Sepsis

Our next blog covers AATB’s comments for the FDA with regard to their draft guidance on Sepsis

Read More
Update: Comment Period Ends – AATB Response to FDA Draft Guidance Document Mycobacterium Tuberculosis
Katie Laney 7/21/25 Katie Laney 7/21/25

Update: Comment Period Ends – AATB Response to FDA Draft Guidance Document Mycobacterium Tuberculosis

Our newest blog highlights the AATB’s comments to the FDA’s draft guidance ““Recommendations to Reduce the Risk of Transmission of Mycobacterium tuberculosis (Mtb) by Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)”

Read More
Unique Device Identifier (UDI) Requirements for Combination Products
Katie Laney 7/14/25 Katie Laney 7/14/25

Unique Device Identifier (UDI) Requirements for Combination Products

Our latest blog covers the recent draft guidance, “Unique Device Identifier (UDI) Requirements for Combination Products” that is currently in its comment period.

Read More
FDA’s Remote Regulatory Assessment (RRA) Guidance Update
Katie Laney 6/30/25 Katie Laney 6/30/25

FDA’s Remote Regulatory Assessment (RRA) Guidance Update

Our latest blog covers the establishment of the Remote Regulatory Assessment (RRA) and the FDA’s final guidance, “Conducting Remote Regulatory Assessments”

Read More
FDA Inspections: Focus Points for Biologics, Medical Device, & Drug Manufacturers
Katie Laney 6/23/25 Katie Laney 6/23/25

FDA Inspections: Focus Points for Biologics, Medical Device, & Drug Manufacturers

Our newest blog covers FDA inspections, and what their top observations are relevant to Biologics, Medical Devices, and Drug Products

Read More
Older Posts

Made with Squarespace

About

Services

Blogs

Testimonials

Resources

Questions?

Contact us